Herpes Simplex Clinical Trial
Official title:
An Open Study in Healthy Herpes Simplex Virus (HSV)-Positive Adults to Evaluate the Safety of GSK Biologicals' Candidate gD Vaccine, With or Without 3D MPL
The purpose of the study is to evaluate the safety and reactogenicity of candidate gD vaccine, with or without MPL, in HSV-seropositive subjects. The immune response elicited in these subjects will also be evaluated.
At the time of conduct of this study, the sponsor GlaxoSmithKline was known by its former name SmithKline Beecham ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05468619 -
Neonatal Phase 1 Valacyclovir Study
|
Phase 1 | |
| Withdrawn |
NCT02349828 -
Antiviral Prophylaxis in a Burn Population
|
Phase 2/Phase 3 | |
| Recruiting |
NCT01176409 -
Can Valacyclovir Attenuate Inflammation in Antiretroviral-Treated HIV-Infected Individuals With Herpes Simplex Virus Type 2?
|
Phase 3 | |
| Completed |
NCT04664127 -
Study of the Efficacy and Safety of Combined Treatment of Patients With Severe Herpes Simplex (HSV) Infection by Valacyclovir and Interferon Inducer Kagocel
|
||
| Completed |
NCT00448227 -
Pharmacokinetics, Acceptability and Safety of Famciclovir in Infants (1 Month to Less Than 12 Months) With Herpes Simplex Infection
|
Phase 2 | |
| Completed |
NCT00000139 -
Herpetic Eye Disease Study (HEDS) II
|
Phase 3 | |
| Completed |
NCT04239521 -
The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata
|
||
| Completed |
NCT02209324 -
Open-label Study of ASP2151 in Herpes Simplex Patients
|
Phase 3 | |
| Completed |
NCT00855309 -
Acyclovir in Preventing Herpes Simplex Virus Infection in Patients With Neutropenia
|
Phase 3 | |
| Completed |
NCT01602562 -
Valaciclovir Hydrochloride Phase III for Hematopoietic Stem Cell Transplantation Patients
|
Phase 3 | |
| Completed |
NCT00973466 -
Prevalence of Sexually Transmitted Infections (STIs) in HIV-infected Patients
|
N/A | |
| Active, not recruiting |
NCT05298254 -
A Study on the Reactogenicity, Safety, Immune Response, and Efficacy of a Targeted Immunotherapy Against HSV in Healthy Participants Aged 18-40 Years or in Participants Aged 18-60 Years With Recurrent Genital Herpes
|
Phase 1/Phase 2 | |
| Recruiting |
NCT03178747 -
Tzanck Smear With Methylene Blue Stain for Herpes
|
Phase 3 | |
| Completed |
NCT00164424 -
Episodic Acyclovir Therapy for Genital Ulcers
|
Phase 2/Phase 3 | |
| Completed |
NCT00161434 -
A Study of Valacyclovir to Suppress HSV and HIV Shedding in Coinfected Persons
|
Phase 4 | |
| Terminated |
NCT04762511 -
A Study on the Reactogenicity, Safety and Immune Response of a Vaccine Against Herpes Simplex Virus (HSV)-2 in Healthy Participants Aged 18-40 Years
|
Phase 1 | |
| Completed |
NCT00699764 -
Safety of a Herpes Simplex Candidate Vaccine (gD2t) With MPL and Its Efficacy to Prevent Genital Herpes Disease
|
Phase 3 | |
| Recruiting |
NCT04065971 -
Randomized, Placebo-controlled, Double-blind Study of 2LHERP® in Orofacial Herpes Infections.
|
Phase 4 | |
| Active, not recruiting |
NCT00005663 -
A Study of Valacyclovir as Treatment for Genital Herpes Simplex Virus in HIV-Infected Patients
|
Phase 3 | |
| Recruiting |
NCT00006132 -
Phase III Randomized Study of Oral Acyclovir in Infants With Herpes Simplex Virus Infection Involving the Central Nervous System
|
Phase 3 |